ArticleJournal of experimental & clinical cancer research : CR2019

CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.

Yichong Ning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.